Answers are grounded in this paper and cite their sources.
The European Union's One Substance, One Assessment (OSOA) legislative package entered into force in January 2026, with a common chemicals data platform envisaged for 2028. Its promise is better reuse of evidence across regulatory regimes, but food-industry decisions expose a deeper difficulty: the same chemical identity may correspond to different mixtures, uses, exposure pathways and legal classifications. This article examines how harmonised hazard information should—and should not—travel between food additives, processing aids, food-contact materials, industrial cleaning systems and substances used in biotechnology. It distinguishes molecular identity from material identity, hazard from risk, and data interoperability from legal authorisation. Comparative analysis considers the EU, Spain, Great Britain and the United States, with particular attention to impurity profiles, transformation products, analytical detection and operator responsibility. A proposed research architecture combines substance-level identifiers with process and exposure metadata to test whether cross-regime evidence can improve early warning without creating false equivalence. The commercial lesson is that shared chemical data can sharpen decisions, but cannot replace use-specific safety demonstrations.
No takes yet. Share an insight, caveat, or question.
Jose Manuel López (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: